Allarity Therapeutics, Inc. · NASDAQ:ALLR

McLaughlin Gerald W. received 45,000 Allarity Therapeutics, Inc. shares as an award (Form 4)

Traded Jan 28, 2026 · Filed May 7, 2026

On Jan 28, 2026, McLaughlin Gerald W. (Director) received 45,000 Allarity Therapeutics, Inc. shares as an award, leaving 70,000 shares. Filed May 7, 2026 (Form 4).

Awarded
45,000 shares
Holding after
70,000 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jan 28, 2026Common StockAward45,00070,000Direct

Source

View original at SEC

Related